跳至主要内容
临床试验/NCT02286648
NCT02286648Unknown4 期

Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars

Mashhad University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
50
试验地点
1
主要终点
successful outcome of treatment as indicated by clinical signs defined with observation and check list

研究概览

简要总结

The purpose of this study is to evaluate the clinical and radiographic success rate of Miniature pulpotomy with Mineral Trioxide Aggregate (MTA) in primary molars.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
4 Years 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • healthy people(without any systemic disease)
  • no clinical or radiographic evidence of pulp degeneration
  • the possibility of proper restoration of the teeth

排除标准

  • excessive bleeding from the exposure site
  • internal root resorption
  • interradicular and/or periapical bone destruction
  • swelling or sinus tract

研究组 & 干预措施

Mineral Trioxide Aggregate

Experimental

pulpotomy with MTA

干预措施: Mineral Trioxide Aggregate (Drug)

Formocresol

Active Comparator

pulpotomy with FC

干预措施: Formocresol (Drug)

结局指标

主要结局

successful outcome of treatment as indicated by clinical signs defined with observation and check list

时间窗: up to 12 months

success or failure of treatment defined with observation and check list

次要结局

  • successful outcome of treatment as indicated by radiographic signs defined with observation and check list(up to 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hossein Nematollahi

principal investigator

Mashhad University of Medical Sciences

研究点 (1)

Loading locations...

相似试验

Success Rate Evaluation of Miniature Pulpotomy With... | 临床试验